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The prevalence of obstructive sleep apnoea and its association
with aortic dilatation in Marfan's syndrome
Abstract
BACKGROUND: Craniofacial abnormalities and increased pharyngeal collapsibility due to abnormal
connective tissue suggest the possibility of an increased prevalence of obstructive sleep apnoea (OSA)
in patients with Marfan's syndrome but the actual prevalence is uncertain. Aortic dilatation and
dissection are life threatening manifestations of Marfan's syndrome and case reports have suggested a
possible association with OSA but data from cohort studies are not available. METHODS: A sleep study
was performed in 61 patients with Ghent criteria positive Marfan's syndrome (mean age 38.3 (SD 12.9)
years; 37 females) and in 26 control subjects matched for age, gender, height and weight. OSA was
defined using two conventional levels of apnoea-hypopnoea index (AHI), >5 and >15/h. In patients with
Marfan's syndrome, aortic root diameter was measured by echocardiography. RESULTS: More patients
with Marfan's syndrome than controls had OSA (AHI >5, 32.8% compared with 11.5%, mean difference
+21.3%, 95% CI 4.2% to 38.3%, p = 0.04; AHI >15, 18.0% compared with 0%, mean difference
+18.0%, 95% CI 8.4% to 27.7%, p = 0.02). AHI was correlated with aortic root diameter (r = 0.50, 95%
CI 0.26 to 0.69, p = 0.0003), and mean aortic root diameter was significantly greater in patients with
OSA (4.5 (SD 0.6) cm) compared with those without OSA (3.7 (0.6) cm) (mean difference 0.8 cm, 95%
CI 0.4 to 1.2 cm, p<0.0001). CONCLUSIONS: In patients with Marfan's syndrome, the prevalence of
OSA is considerably higher than in matched control subjects. OSA may be a risk factor for aortic root
dilatation in Marfan's syndrome.
doi: 10.1136/thx.2008.102756
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ABSTRACT
Background: Craniofacial abnormalities and increased
pharyngeal collapsibility due to abnormal connective
tissue suggest the possibility of an increased prevalence
of obstructive sleep apnoea (OSA) in patients with
Marfan’s syndrome but the actual prevalence is uncertain.
Aortic dilatation and dissection are life threatening
manifestations of Marfan’s syndrome and case reports
have suggested a possible association with OSA but data
from cohort studies are not available.
Methods: A sleep study was performed in 61 patients
with Ghent criteria positive Marfan’s syndrome (mean age
38.3 (SD 12.9) years; 37 females) and in 26 control
subjects matched for age, gender, height and weight.
OSA was defined using two conventional levels of
apnoea–hypopnoea index (AHI), .5 and .15/h. In
patients with Marfan’s syndrome, aortic root diameter
was measured by echocardiography.
Results: More patients with Marfan’s syndrome than
controls had OSA (AHI .5, 32.8% compared with 11.5%,
mean difference +21.3%, 95% CI 4.2% to 38.3%,
p = 0.04; AHI .15, 18.0% compared with 0%, mean
difference +18.0%, 95% CI 8.4% to 27.7%, p = 0.02). AHI
was correlated with aortic root diameter (r = 0.50, 95%
CI 0.26 to 0.69, p = 0.0003), and mean aortic root
diameter was significantly greater in patients with OSA
(4.5 (SD 0.6) cm) compared with those without OSA (3.7
(0.6) cm) (mean difference 0.8 cm, 95% CI 0.4 to
1.2 cm, p,0.0001).
Conclusions: In patients with Marfan’s syndrome, the
prevalence of OSA is considerably higher than in matched
control subjects. OSA may be a risk factor for aortic root
dilatation in Marfan’s syndrome.
Marfan’s syndrome is an autosomal dominant
inherited multisystem disorder. It is caused by
mutations in the FBN1 gene localised on chromo-
some 15q21, which encodes the matrix protein
fibrillin 1. The incidence of Marfan’s syndrome is
estimated to be 2–3 per 10 000 individuals.1 To
date there is no rapid and efficient molecular
diagnostic test to identify individuals with the
disease and thus the diagnosis primarily depends
on a combination of major and minor clinical
findings defined in the ‘‘Ghent criteria’’.2 3 The
hallmark clinical features are noted in the cardio-
vascular, ocular and skeletal systems.
Aortic root dilatation and subsequent dissection
are the commonest life threatening manifestations
of Marfan’s syndrome. Dilatation of the aortic root
can begin in childhood or early adulthood and
increases at an unpredictable rate.4 5 It is still a
matter of debate which factors contribute to rapid
progression of aortic root dilatation.
The high prevalence of craniofacial dysmorph-
isms and an increased upper airway collapsibility6
could predispose to an increased prevalence of
obstructive sleep apnoea (OSA) in patients with
Marfan’s syndrome but there is only very limited
information in the literature concerning the actual
prevalence of OSA in this patient group. Cistulli
and Sullivan7 reported a prevalence of 64% (defined
by a apnoea–hypopnoea index (AHI) .5) but
interpretation of this finding is limited as only 25
subjects with Marfan’s syndrome were included in
the study.
A possible causal link between OSA and aortic
dilatation in patients with Marfan’s syndrome has
been suggested in two case reports.8 9 Possible
underlying pathophysiological mechanisms are
post-apnoea reflex sympathetic activation and
consequent marked increases in blood pressure,10
which produce shear stresses in blood vessel
walls—forces that are thought to cause vascular
wall damage.11 Furthermore, largely negative
intrathoracic pressure swings, which are produced
during obstructive apnoeas, increase transaortic
pressures12 and may therefore accelerate aortic
dilatation. To date, there are no data from cohort
studies that have investigated the possible associa-
tion of OSA with aortic root dilatation in patients
with Marfan’s syndrome.
We have addressed this issue by performing a
case control study to evaluate the prevalence of
OSA and its possible correlation with aortic root
dilatation in a large cohort of patients with
Marfan’s syndrome.
METHODS
Patients and controls
Patients fulfilling the Ghent criteria2 3 for Marfan’s
syndrome and attending their yearly clinical
assessment at our institution were asked to
participate in the study. Control subjects were
recruited from the local population by an adver-
tisement which was placed in the Oxford Radcliffe
Hospitals NHS Trust sites and selected from
among the volunteers to match subjects with
Marfan’s syndrome as closely as possible for
average/frequency of age, gender, height and
weight in order to compare the prevalence of
OSA. Subjects were eligible if they were between
18 and 75 years of age, not pregnant and not
treated with continuous positive airway pressure
(CPAP). The study was approved by the Oxford
research ethics committee (REC No 07/Q1607/6)
Sleep-disordered breathing
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and written informed consent was obtained from all
participants.
Measurements
Anthropometrics and blood pressure
The following anthropometric parameters were measured in all
participants: height, weight, neck circumference, cricomental
distance, palatal height, and maxillary and mandibular inter-
molar distance by callipers according to the method described
by Kushida and colleagues.13 Tonsillar enlargement was assessed
as previously described (class I, tonsils absent; class II, tonsils do
not extend beyond the palatopharyngeal arch; class III, tonsils
at the palatopharyngeal arch; class IV, tonsils extend beyond
the palatopharyngeal arch).14 Palatal position or tongue size was
assessed by the Mallampati score (class I, all of the oropharynx
including tonsils, pillars, soft palate and tip of the uvula are
visible; class II, tonsils’ upper pole and uvula visible; class III,
part of the uvula and soft palate visible; class IV, hard palate and
part of soft palate are barely visible).15 16 The facial profile was
categorised as retrognathic, neutral or prognathic in Frankfurt
position,17 and the dental overbite was measured by a calliper, as
previously described.14
Blood pressure and heart rate were measured in the sitting
position with a standard digital automatic monitor (Omron
Healthcare Company, Kyoto, Japan). The mean value of three
readings was used for analysis.
Sleep studies and questionnaire
Subjective sleepiness was assessed using the Epworth Sleepiness
Scale (ESS) questionnaire. Home sleep studies were performed
using the ApneaLink device (ResMed, MAP Medicine
Technology, Martinsried, Germany). The device records the
patient’s nasal respiratory pressure signal and finger oximetry
during sleep, and has been validated as an accurate instrument
to detect snoring, apnoea–hypopnoea and oxygen desatura-
tions.18 The results of the sleep study were scored automatically
with dedicated software (ResMed, MAP Medicine Technology),
with manual review to ensure accuracy of the data. Apnoeas
were defined as a cessation of airflow lasting .10 s and
hypopnoeas as a reduction in airflow of at least 50% lasting
.10 s, associated with a drop in oxygen saturation of .4%.
Snoring severity was quantified as the number of snoring events
per hour of study. OSA severity was quantified as the number
of apnoeas–hypopnoeas (AHI) and oxygen desaturations .4%
per hour of study (ODI).
Aortic root diameter measurements
In all patients with Marfan’s syndrome, echocardiography was
performed by the same cardiac ultrasound technician who was
not involved in the analysis of the study. Aortic root diameter
was measured in the parasternal long axis view at end diastole
(peak of R wave on electrocardiogram) and at end systole (T
wave on electrocardiogram) by two dimensional, M mode
echocardiography with a commercially available cardiac ultra-
sound system (Sonos 4500; Philips Healthcare, UK) using a
3.5 MHz transducer. The diameter of the aorta was assessed at
several levels: at the left ventricular outflow tract, sinuses of
Valsalva, supraaortic ridge and at the proximal ascending aorta,
1–2 cm above the supraaortic ridge, as described previously.19
The maximal diameter of the aortic root from these four
assessments and the maximal diameter corrected for age and
body surface area (predicted maximal diameter in per cent) were
used for further statistical analysis.19
Data analysis
Data are expressed as means (SD). All statistical analyses were
performed with Statistica V6.0 (StatSoft, Tulsa, Oklahoma,
USA). Non-normally distributed data were normalised by
square root transformation for statistical analysis.
Demographics, results of the sleep study and echocardiography
were compared by independent t tests. In order to define the
prevalence of OSA, two conventional threshold levels of AHI,
.5 and .15/h, were used. The threshold of .5 was also used
for subgroup comparisons of snoring events, subjective daytime
sleepiness and aortic root diameter in patients with and without
OSA. For comparison of frequencies, the x2 test of independence
was used. Pearson’s correlation analysis and multiple linear
regression analysis were used to evaluate the relationships
between the apnoea index (AI), AHI, ODI, anthropometrics and
maximal aortic root diameter. A p value ,0.05 was considered
to be statistically significant.
Figure 1 Study profile.
Table 1 Participant’s characteristics
Marfan’s
(n = 61)
Controls
(n = 26)
Age (years) 38.3 (12.9) 37.2 (9.8)
Sex (W/M) 37/24 14/12
Height (m) 1.80 (0.11) 1.80 (0.10)
Weight (kg) 81.4 (20.5) 78.1 (15.0)
BMI (kg/m2) 25.1 (5.9) 24.0 (4.3)
Systolic BP (mm Hg) 123.7 (14.2) 118.8 (11.9)
Diastolic BP (mm Hg) 76.2 (11.0) 74.4 (9.8)
Heart rate (/min) 62.5 (9.9) 65.0 (9.8)
Values are mean (SD).
BMI, body mass index; BP, blood pressure.
Sleep-disordered breathing
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RESULTS
Study profile and participants characteristics
Figure 1 shows the study profile. Sixty-one patients with Ghent
criteria positive Marfan’s syndrome and 26 controls completed the
study protocol. Patients with Marfan’s syndrome were recruited
from 41 unrelated families (no apparent relationships in their
pedigree) of which 32 families provided one patient and nine
families provided two or multiple patients (mostly first degree
relatives). The two groups were similar (no statistically significant
difference) regarding age, gender distribution, height, weight,
body mass index (BMI), blood pressure and heart rate (table 1).
Patients with Marfan’s syndrome were not different from
control subjects regarding neck circumference, cricomental
distance, dental overbite, Mallampati and tonsillar size score,
and retrognathic face profile but palatal height was significantly
greater and maxillar/mandibular intermolar distance was sig-
nificantly smaller in patients with Marfan’s syndrome (table 2).
Sleep study, subjective sleepiness and predictors of OSA
Sleep study and subjective sleepiness
AHI and ODI were significantly higher in patients with
Marfan’s syndrome compared with control subjects (table 3).
Twenty patients with Marfan’s syndrome (nine females) had an
AHI .5 compared with three subjects in the control group (one
female). Eleven patients with Marfan’s syndrome had an AHI
.15 compared with none in the control group. Eighteen
patients with Marfan’s syndrome had an ODI .5 compared
with only one patient in the control group (table 3, fig 2).
Inspection of the data showed that the 20 cases with an AHI.5
were distributed across 16 of the 41 families.
As expected, Marfan’s patients with an AHI .5 had more
snoring events per hour (83.0 (94.8)/h) than patients with an
AHI ,5 (28.9 (49.1)/h) indicating that apnoeas were of the
obstructive type (mean difference 54.1 events, 95% CI 17.4 to
90.8 events, p = 0.006).
Subjective daytime sleepiness assessed by the ESS was higher
in patients with Marfan’s syndrome compared with controls
(table 3).
Patients with an AHI .5 did not have a higher ESS (7.6 (4.3))
than patients with an AHI,5 (7.9 (5.5)) (mean difference20.3,
95% CI 23.1 to +2.5, p = 0.83).
Table 2 Head and neck anthropometrics
Marfan’s
(n = 61)
Controls
(n = 26) p Value
Neck circumference (cm) 36.5 (3.6) 36.6 (4.2) 0.85
Cricomental distance (cm) 7.7 (1.2) 8.1 (0.9) 0.078
Dental overbite (mm) 3.5 (2.7) 3.9 (1.7) 0.48
Palatal height (cm) 4.0 (0.7) 3.7 (0.7) 0.029
Maxillar intermolar distance (cm) 3.1 (0.4) 3.5 (0.5) ,0.0001
Mandibular intermolar distance (cm) 2.9 (0.4) 3.6 (0.5) ,0.0001
% Retrognathic 21.3 15.4 0.26
Mallampati classes (%)* 30/44/18/8 38/50/12/0 0.36
Tonsillar size classes (%)* 8/74/11/7 0/77/19/4 0.36
Values are mean (SD).
*Percentage of subjects in each of the four classes (I/II/III/IV).
Table 3 Sleep study and subjective sleepiness
Marfan’s
(n = 61)
Controls
(n = 26) Difference
95% CI of
difference p Value
AHI 5.5 (0.9–13.9) 3.0 (1.5–5.2) +0.37 0.003 to 1.37 0.03
% patients with AHI .5 32.8 11.5 +21.3 4.2 to 38.3 0.04
% patients with AHI .15 18.0 0 +18.0 8.4 to 27.7 0.02
ODI 3.2 (0.3–9.1) 1.3 (0.1–3.8) +0.41 0.01 to 1.37 0.02
% patients with ODI .5 29.5 3.9 +25.7 12.0 to 39.3 0.008
ESS 7.8 (5.1) 4.6 (3.2) +3.2 1.1 to 5.4 0.004
Values for AHI and ODI are mean and 1 SD range (via square root transformation, and back-transformation, to normalise the
distribution). Values for ESS are mean (SD).
Because of displacement of the nasal cannulae, AHI could not be calculated in two patients with Marfan’s syndrome; the ODI was
,5 in both subjects.
AHI, apnoea–hypopnoea index; ESS, Epworth Sleepiness Scale; ODI, oxygen desaturation index.
Figure 2 Apnoea–hypopnoea index (A) and oxygen desaturation index
(ODI) (B) in patients with Marfan’s syndrome (filled symbols) and
controls (open symbols). Significantly more patients with Marfan’s
syndrome compared with the control group had an apnoea–hypopnoea
index of .5 (32.8% vs 11.3%, p = 0.04) and .15 (18.0% vs 0%,
p = 0.02), and an ODI .5 (29.5% vs 3.9%, p = 0.008).
Sleep-disordered breathing
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Predictors of OSA
There was a significant correlation between AHI and age
(r = 0.37, p = 0.004), BMI (r = 0.54, p = 0.00001) and neck
circumference (r = 0.45, p = 0.0004) in patients with Marfan’s
syndrome. In a multiple linear regression model, 33% of the
variation in AHI could be explained by these factors (r2 = 0.33,
p,0.0001) although only BMI appeared to be an independent
predictor of AHI.
ODI was significantly correlated with age (r = 0.44,
p = 0.0004), BMI (0.70, p,0.0001) and neck circumference
(r = 0.43, p = 0.0007). In a multiple linear regression model, 54%
of the variation in ODI could be explained by these factors
(r2 = 0.54, p,0.0001), and again only BMI was an independent
predictor of ODI.
Aortic root diameter
Of the 61 patients with Marfan’s syndrome, 12 patients (19.7%)
had previously undergone surgery for aortic root dilatation. In
non-operated patients, mean aortic root diameter was signifi-
cantly higher in subjects with an AHI .5 (n = 16, 4.5 (0.6) cm)
than in subjects with an AHI ,5 (n = 33, 3.7 (0.6) cm) (mean
difference +0.8 cm, 95% CI 0.4 to 1.2 cm, p,0.0001). Per cent
predicted aortic root diameter (corrected for age and body
surface area) was higher in patients with AHI .5 (127.8
(19.3)%) than in patients with AHI ,5 (116.8 (15.9)%) (mean
difference 11%, 95% CI 0.6 to 21.5%, p = 0.039).
In non-operated patients, aortic root diameter was strongly
correlated with AI and AHI (r = 0.50, 95% CI 0.26 to 0.69,
p = 0.0003 for both correlations) (fig 3) and, as expected, with
body surface area (r = 0.47, 95% CI 0.22 to 0.66, p = 0.0007) and
age (r = 0.40, 95% CI 0.13 to 0.61, p = 0.005). When aortic root
diameter was expressed as per cent predicted, it was still
significantly correlated with AI (r = 0.32, 95% CI 0.04 to 0.55,
p = 0.028) whereas the correlation with AHI (r = 0.27, 95% CI
20.01 to 0.51, p = 0.068) did not quite attain statistical
significance.
DISCUSSION
This is the first large case control study on the prevalence of
OSA in patients with Marfan’s syndrome showing a consider-
ably higher frequency of OSA in patients with Marfan’s
syndrome compared with matched control subjects using either
a threshold for AHI of .5 or .15. This is also the first study
providing data on the relationship between OSA and aortic root
dilatation in patients with Marfan’s syndrome. We found an
association between the severity of OSA and the diameter of the
aortic root, which suggests that OSA may be a risk factor for
aortic root dilatation in patients with Marfan’s syndrome.
In this study, we found that approximately 30% of all
patients with Marfan’s syndrome had an AHI and ODI of .5,
which is a considerably higher prevalence of OSA than in our
matched controls (3.9% had an ODI .5) or in a UK population
based epidemiological study (5% had an ODI .5).20 However,
Cistulli and Sullivan7 reported that 16 of 25 patients (64%) with
Marfan’s syndrome had OSA (defined as AHI .5). A possible
explanation for the very high prevalence of OSA found in the
latter study may be selection bias due to the relatively small
number of randomly recruited patients whereas we screened all
patients attending the Oxford Marfan’s clinic for eligibility and
invited every patient with Ghent positive Marfan’s syndrome to
take part in the study. Another contributory explanation may
be the higher percentage of females in our study (60% compared
with 52% in the study by Cistulli and Sullivan)7 as the
prevalence of OSA is known to be lower in women than in
men.21 In the only other study on the prevalence of sleep
disorders in Marfan’s syndrome, Verbraecken and colleagues22
found that four of 15 patients (27%) had features and
symptoms of sleep apnoea although this study was based on
questionnaires only.
A high frequency of craniofacial abnormalities and an
increased upper airway collapsibility, resulting from the
abnormally lax connective tissue, have previously been sug-
gested as possible underlying causes for the high prevalence of
OSA found in patients with Marfan’s syndrome.6 23 In contrast
with an earlier uncontrolled study in 15 patients with Marfan’s
syndrome,23 we found that patients with Marfan’s syndrome
were not different from control subjects regarding the frequency
of a retrognathic facial profile, mean neck circumference,
cricomental distance or Mallampati score, all of which are
clinical features well known to be associated with OSA.24 25 The
shorter intermolar distance and the greater palatal height we
found in patients with Marfan’s syndrome in comparison with
control subjects are unlikely to contribute to the pathogenesis
of OSA as there was no correlation between these measures and
OSA severity, assessed by AHI, in our cohort (data not shown).
Therefore, it seems that the higher prevalence of OSA found in
patients with Marfan’s syndrome is more likely to be the result
of an increased upper airway collapsibility rather than of
craniofacial abnormalities.
The high prevalence of OSA in Marfan’s syndrome raises the
question of how should an individual be assessed for potential
OSA. We identified BMI as the only independent predictor of
OSA in patients with Marfan’s syndrome and unexpectedly the
degree of subjective sleepiness was not related to the severity of
OSA. This suggests that simply assessing a patient’s subjective
sleepiness is not a useful method to screen for OSA in a cohort
of Marfan’s patients. Therefore, a detailed medical history,
including questions on snoring, apnoeas and sleepiness, together
with an assessment of BMI, is warranted in every patient with
Marfan’s syndrome and may help the clinician to decide
whether a sleep study should be performed.
Aortic root dilatation and subsequent dissection are the most
life threatening manifestations of Marfan’s syndrome.
Dilatation of the aortic root can begin in childhood or early
adulthood and increases at an unpredictable rate.4 5 It is still a
matter of debate which factors contribute to rapid progression
Figure 3 In patients with Marfan’s syndrome, the apnoea–hypopnoea
index showed a strong relationship with the diameter of the aortic root
(r = 0.50, 95% CI 0.26 to 0.69, p = 0.0003). The solid line represents the
regression line according to the function: aortic root diameter = 3.66 +
0.36 6 apnoea/hypopnoea index.
Sleep-disordered breathing
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of aortic root dilatation. This is the first study in which the
potential relationship between OSA and aortic root dilatation in
patients with Marfan’s syndrome has been investigated. Our
data show that the severity of OSA is associated with an
increased aortic root diameter (fig 3), and patients with OSA
had a larger aortic root than patients without OSA. These
results are corroborated by the findings of two case reports in
which treatment of OSA with CPAP was associated with
attenuation of aortic root dilatation in three patients with
Marfan’s syndrome.8 9 This suggests that OSA promotes aortic
dilatation in patients with Marfan’s syndrome. To date, the
underlying mechanisms through which OSA may promote
aortic dilatation in these patients are not clear. OSA has been
shown to be associated with increased diurnal blood pressure as
well as with recurrent surges in blood pressure during apnoeic
events,26 which is the main risk factor for aortic dilatation and
dissection.27 In addition, obstructive apnoeas are associated with
repeated inspiratory effort against the collapsed upper airway,
causing recurrent large subatmospheric intrathoracic pressure
swings (sometimes over 60 mm Hg) and thereby producing
extensive shear stresses on intrathoracic structures, including
the ascending aorta.28 This hypothesis is supported by the
findings of Peters et al who reported increased aortic diameters
during obstructive apnoeas in an animal model.29 30
Furthermore, Sampol and colleagues31 recently found that
(non-Marfan’s) patients with dissection of the thoracic aorta
had a higher apnoea–hypopnoea index versus well matched
hypertensive control subjects without dissection (28 (30) vs 11
(10); p = 0.03). However, a randomised controlled trial on the
effects of CPAP on aortic root diameter in patients with OSA
and Marfan’s syndrome is required to prove if treatment of OSA
indeed attenuates the progression of aortic dilatation.
In conclusion, we have shown that OSA is highly prevalent in
patients with Marfan’s syndrome. It is not possible to reliably
predict the presence of OSA in these patients by assessment of
subjective sleepiness or facial morphological features. OSA may
be a risk factor for aortic dilatation in patients with Marfan’s
syndrome, and randomised controlled trials investigating the
effects of continuous positive airway pressure on aortic
dilatation are warranted to definitely prove this relationship.
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